Magee, C., D.J. Grieve, C.J. Watson, and D.P. Brazil. 2017. Diabetic Nephropathy: A Tangled Web to Unweave. Cardiovascular Drugs and Therapy 31 (5–6): 579–592. https://doi.org/10.1007/s10557-017-6755-9.
Rossing P. 2006. Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005. Diabetologia 49 (1): 11–19. https://doi.org/10.1007/s00125-005-0077-3.
Loeffler, I., and G. Wolf. 2015. Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction? Cells 4 (4): 631–652. https://doi.org/10.3390/cells4040631.
Ni, W.J., L.Q. Tang, and W. Wei. 2015. Research progress in signalling pathway in diabetic nephropathy. Diabetes/Metabolism Research and Reviews 31 (3): 221–233. https://doi.org/10.1002/dmrr.2568.
Alicic, R.Z., M.T. Rooney, and K.R. Tuttle. 2017. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clinical Journal of the American Society of Nephrology 12 (12): 2032–2045. https://doi.org/10.2215/CJN.11491116.
Ebbesen, K.K., T.B. Hansen, and J. Kjems. 2017. Insights into circular RNA biology. RNA Biology 14 (8): 1035–1045. https://doi.org/10.1080/15476286.2016.1271524.
Hansen, T.B., T.I. Jensen, B.H. Clausen, J.B. Bramsen, B. Finsen, C.K. Damgaard, and J. Kjems. 2013. Natural RNA circles function as efficient microRNA sponges. Nature 495 (7441): 384–388. https://doi.org/10.1038/nature11993.
Han, B., J. Chao, and H. Yao. 2018. Circular RNA and its mechanisms in disease: From the bench to the clinic. Pharmacology & Therapeutics 187: 31–44. https://doi.org/10.1016/j.pharmthera.2018.01.010.
Zhao, L., H. Chen, Y. Zeng, K. Yang, R. Zhang, Z. Li, T. Yang, and H. Ruan. 2021. Circular RNA circ_0000712 regulates high glucose-induced apoptosis, inflammation, oxidative stress, and fibrosis in (DN) by targeting the miR-879-5p/SOX6 axis. Endocrine Journal. https://doi.org/10.1507/endocrj.EJ20-0739.
An, L., D. Ji, W. Hu, J. Wang, X. Jin, Y. Qu, and N. Zhang. 2020. Interference of Hsa_circ_0003928 Alleviates High Glucose-Induced Cell Apoptosis and Inflammation in HK-2 Cells via miR-151-3p/Anxa2. Diabetes, Metabolic Syndrome and Obesity 13: 3157–3168. https://doi.org/10.2147/DMSO.S265543.
Yang, L., X. Han, C. Zhang, C. Sun, S. Huang, W. Xiao, Y. Gao, Q. Liang, F. Luo, W. Lu, J. Fu, and Y. Zhou. 2020. Hsa_circ_0060450 Negatively Regulates Type I Interferon-Induced Inflammation by Serving as miR-199a-5p Sponge in Type 1 Diabetes Mellitus. Frontiers in Immunology 11: 576903. https://doi.org/10.3389/fimmu.2020.576903.
Tang, J., D. Yao, H. Yan, X. Chen, L. Wang, and H. Zhan. 2019. The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy. International Journal of Endocrinology 2019: 8719060. https://doi.org/10.1155/2019/8719060.
Liu, L., H. Chen, J. Yun, L. Song, X. Ma, S. Luo, and Y. Song. 2021. miRNA-483-5p Targets HDCA4 to Regulate Renal Tubular Damage in Diabetic Nephropathy. Hormone and Metabolic Research. https://doi.org/10.1055/a-1480-7519.
Chen, X., L. Gu, X. Cheng, J. Xing, and M. Zhang. 2021. MiR-17-5p downregulation alleviates apoptosis and fibrosis in high glucose-induced human mesangial cells through inactivation of Wnt/beta-catenin signaling by targeting KIF23. Environmental Toxicology. https://doi.org/10.1002/tox.23280.
Wei, B., Y.S. Liu, and H.X. Guan. 2020. MicroRNA-145-5p attenuates high glucose-induced apoptosis by targeting the Notch signaling pathway in podocytes. Experimental and Therapeutic Medicine 19 (3): 1915–1924. https://doi.org/10.3892/etm.2020.8427.
Liang, W., B. Guo, J. Ye, H. Liu, W. Deng, C. Lin, X. Zhong, and L. Wang. 2019. Vasorin stimulates malignant progression and angiogenesis in glioma. Cancer Science 110 (8): 2558–2572. https://doi.org/10.1111/cas.14103.
Bhandari, A., Y. Guan, E. Xia, Q. Huang, and Y. Chen. 2019. VASN promotes YAP/TAZ and EMT pathway in thyroid carcinogenesis in vitro. American Journal of Translational Research 11 (6): 3589–3599.
Cui F.L., A.N., Mahmud, Z.P. Xu, Z.Y. Wang, and J.P. Hu. 2020. VASN promotes proliferation of prostate cancer through the YAP/TAZ axis. European Review for Medical and Pharmacological Sciences 24 (12): 6589–6596. https://doi.org/10.26355/eurrev_202006_21644.
Ahn, J.M., B.G. Kim, M.H. Yu, I.K. Lee, and J.Y. Cho. 2010. Identification of diabetic nephropathy-selective proteins in human plasma by multi-lectin affinity chromatography and LC-MS/MS. Proteomics. Clinical Applications 4 (6–7): 644–653. https://doi.org/10.1002/prca.200900196.
Jin, J., H. Sun, C. Shi, H. Yang, Y. Wu, W. Li, Y.H. Dong, L. Cai, and X.M. Meng. 2020. Circular RNA in renal diseases. Journal of Cellular and Molecular Medicine 24 (12): 6523–6533. https://doi.org/10.1111/jcmm.15295.
Zhang, J.R., and H.J. Sun. 2020. Roles of circular RNAs in diabetic complications: From molecular mechanisms to therapeutic potential. Gene 763: 145066. https://doi.org/10.1016/j.gene.2020.145066.
Meng, Q., X. Zhai, Y. Yuan, Q. Ji, and P. Zhang. 2020. lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy. Brazilian Journal of Medical and Biological Research 53 (4): e9288. https://doi.org/10.1590/1414-431X20209288.
Wang, J., and S.M. Zhao. 2021. LncRNA-antisense non-coding RNA in the INK4 locus promotes pyroptosis via miR-497/thioredoxin-interacting protein axis in diabetic nephropathy. Life Sciences 264: 118728. https://doi.org/10.1016/j.lfs.2020.118728.
Liu, H., X. Wang, Z.Y. Wang, and L. Li. 2020. Circ_0080425 inhibits cell proliferation and fibrosis in diabetic nephropathy via sponging miR-24-3p and targeting fibroblast growth factor 11. Journal of Cellular Physiology 235 (5): 4520–4529. https://doi.org/10.1002/jcp.29329.
Tang, B., W. Li, T.T. Ji, X.Y. Li, X. Qu, L. Feng, and S. Bai. 2020. Circ-AKT3 inhibits the accumulation of extracellular matrix of mesangial cells in diabetic nephropathy via modulating miR-296-3p/E-cadherin signals. Journal of Cellular and Molecular Medicine 24 (15): 8779–8788. https://doi.org/10.1111/jcmm.15513.
Li, J., X. Jiang, L. Duan, and W. Wang. 2019. Long non-coding RNA MEG3 impacts diabetic nephropathy progression through sponging miR-145. American Journal of Translational Research 11 (10): 6691–6698.
Liu B., L. Qiang, G.D. Wang, Q. Duan, and J. Liu. 2019. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis. European Review for Medical and Pharmacological Sciences 23 (8): 3478–3486. https://doi.org/10.26355/eurrev_201904_17713.